Renaissance Capital logo

Adverum Biotechnologies (Avalanche) Priced, Nasdaq: ADVM

Early-stage biotech developing a gene therapy for wet AMD.

Industry: Health Care

First Day Return: +64.6%

Industry: Health Care

Early-stage biotech developing a gene therapy for wet AMD.
more less

Adverum Biotechnologies (Avalanche) (ADVM) Performance